Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The struggle to detect circulating DNA.

Sacha Zeerleder1

  • 1Sanquin Research at CLB, Department of Immunopathology, Plesmanlaan 125, 1066 CX Amsterdam, The Netherlands. s.zeerleder@sanquin.nl

Critical Care (London, England)
|May 25, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case report: Challenging diagnosis of leukocytoclastic vasculitis, caused by recurrent urinary tract infection.

SAGE open medical case reports·2026
Same author

Quantifying endothelial damage by digital droplet polymerase chain reaction (PCR) of endothelial cell-free DNA in COVID-19 patients.

Research and practice in thrombosis and haemostasis·2026
Same author

Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.

Swiss medical weekly·2024
Same author

A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications.

International journal of molecular sciences·2024
Same author

Plasma Exchange Therapy Using Solvent Detergent-Treated Plasma: An Observational Pilot Study on Complement, Neutrophil and Endothelial Cell Activation in a Case Series of Patients Suffering from Atypical Hemolytic Uremic Syndrome.

Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie·2023
Same author

Immunothrombosis and Complement Activation Contribute to Disease Severity and Adverse Outcome in COVID-19.

Journal of innate immunity·2023
Same journal

Obesity: biomechanical implications for mechanical ventilation.

Critical care (London, England)·2026
Same journal

Combined trauma and toxic inhalation in war and disaster medicine: alveolar-capillary barrier failure and respiratory countermeasures.

Critical care (London, England)·2026
Same journal

The molecular ICU: a primer on omics, informatics and the future of precision critical care.

Critical care (London, England)·2026
Same journal

Bilateral radial arterial pressure concordance as a real-time bedside marker of native cardiac recovery during peripheral VA-ECMO weaning.

Critical care (London, England)·2026
Same journal

Beyond shear stress: septic microvascular failure remains a multifactorial phenomenon.

Critical care (London, England)·2026
Same journal

Anticoagulation-free VV-ECMO: expanding the evidence beyond trauma.

Critical care (London, England)·2026
See all related articles

Elevated circulating DNA levels in diseases like cancer and sepsis are measurable but their predictive value is debated. Proper sample handling is crucial for accurate quantification and predicting patient outcomes in intensive care units.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Clinical Diagnostics

Background:

  • Elevated levels of circulating DNA are observed in various critical conditions, including cancer, autoimmune diseases, sepsis, and myocardial infarction.
  • Circulating DNA in plasma exists primarily as protein-bound nucleosomal DNA.
  • Quantification methods include real-time quantitative PCR and immunological assays like ELISA.

Discussion:

  • The predictive value of circulating DNA levels across different diseases remains a subject of ongoing research and debate.
  • Inaccurate sample handling can significantly impair the diagnostic accuracy of both qPCR and ELISA methods for circulating DNA.
  • Assessing circulating DNA in intensive care unit (ICU) patients shows potential for predicting morbidity and mortality.

Key Insights:

Related Experiment Videos

  • Circulating DNA is a potential biomarker in critical illnesses.
  • Methodological factors, particularly sample handling, critically influence assay reliability.
  • ICU patient data suggest prognostic utility for circulating DNA measurements.

Outlook:

  • Further research is needed to standardize quantification methods and validate the predictive power of circulating DNA across diverse patient populations.
  • Optimizing pre-analytical procedures is essential for reliable clinical application of circulating DNA analysis.
  • Exploring the role of circulating DNA in conjunction with other biomarkers may enhance prognostic accuracy in critical care settings.